Fig. 1

HYPERLINK "sps:id::fig1||locator::gr1||MediaObject::0" Effect of FMN in the immune-mediated BMF mouse model. A The establishment of the immune-mediated BMF mouse model and the treatment process. B The levels of white blood cells (WBC), red blood cells (RBC), hemoglobin (HGB), and platelets (PLT) in the peripheral blood of different groups (n = 5). C Bone marrow pathological characteristics in different groups were examined by hematoxylin and eosin staining (200 ×) (n = 5). D The number of nucleated cells and megakaryocytes of bone marrow pathology in different groups (400 ×) (n = 5). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 compared with the model group. #p < 0.05, ###p < 0.001, ####p < 0.0001 compared with the control group